Trading Options with an Edge
Select Page

PDSB

Search by
TICKER SYMBOL

PDS Biotechnology Corporation

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

15.65

-0.73

(-4.457%)

Volume:

499,177

52 week range:

1.87 - 17.85

Market Cap:

444.833M

Company Description:

PDS Biotech is a clinical-stage immunotherapy company with a growing pipeline of cancer immunotherapies and infectious disease vaccines based on the Company's proprietary Versamune® T-cell activating technology platform. Versamune® effectively delivers disease-specific antigens for in vivo uptake and processing, while also activating the critical type 1 interferon immunological pathway, resulting in production of potent disease-specific killer T-cells as well as neutralizing antibodies. PDS Biotech has engineered multiple therapies, based on combinations of Versamune® and disease-specific antigens, designed to train the immune system to better recognize disease cells and effectively attack and destroy them.